New patent to allow assessment of a patient’s attention by using eye tracking technology to change the rate of content delivery to match attention levels.
iStent inject achieved 42 percent reduction in Mean IOP to 14.6 mmHg and 82 percent reduction in mean medications to 0.55 at three years postoperative.